Innate Pharma SA
PAR:IPH

Watchlist Manager
Innate Pharma SA Logo
Innate Pharma SA
PAR:IPH
Watchlist
Price: 1.946 EUR 1.14%
Market Cap: 157.5m EUR
Have any thoughts about
Innate Pharma SA?
Write Note

EV/S
Enterprise Value to Sales

5.9
Current
4.9
Median
7.5
Industry
Higher than median
Lower than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S
5.9
=
Enterprise Value
147.9m EUR
/
Revenue
24.9m EUR
All Countries
Close

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/S
4.1
2-Years Forward
EV/S
2
3-Years Forward
EV/S
1.4

See Also

Discover More